[Arterial hypertension in elderly individuals].
EMERIAU STUDY IN ELDERLY HYPERTENSIVE PATIENTS: This multicenter, randomized, double-blind European study was conducted in 524 elderly patients of mean aged 72 years in three parallel treatment arms (indapamid SR 1.5 mg, amlopidine 5 mg hydrochlorothiazide 25 mg). The study demonstrated an equivalent antihypertensive effect for the three treatment arms and with a mean reduction in diastolic pressure of 23 mmHg. In the indapamid SR group, the rate of normalization was higher, both for elevated systolic-diastolic pressure and elevated systolic pressure, alone. HYVET STUDY: This is an ongoing randomized, double-blind trial designed to confirm the beneficial effect of antihypertensive treatment with indapamid SR in very elderly patients (> 80 years old).